tempol (APC-400)
/ DMK Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
June 30, 2021
Biden Administration Invests $3 Billion in Developing Antiviral COVID-19 Pill
(Verywell Health)
- "'Currently the only respiratory virus that can be treated is influenza, Geoffrey Chupp, MD...tells Verywell. 'There are multiple approved antiviral medications for HIV, hepatitis B, adenovirus, and CMV, so it's perfectly reasonable to expect that we can develop effective antivirals against SARS-CoV-2.'...'It appears that variants will continue to emerge and that people around the world will continue to get infected,' Chupp says. 'Limiting the severity of illness and shortening the recovery will be important for years until it is clear the virus is no longer a threat. Swine flu is still an issue after 100 years.'"
Media quote • Novel Coronavirus Disease
April 15, 2021
"Global Radiation Dermatitis Epidemiology Insight Report 2021-2030 Featuring Tempol (APC-400): Adamis Pharmaceuticals/Matrix Biomed and BMX-001: BioMimetix JV - https://t.co/guyiBzPH8C https://t.co/qPZJWwOHCI"
(@NewsFromBW)
Clinical • Dermatitis • Dermatology • Immunology
1 to 2
Of
2
Go to page
1